Doximity Net Profit Margin 2020-2025 | DOCS

Current and historical net profit margin for Doximity (DOCS) from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Doximity net profit margin for the three months ending March 31, 2025 was .
Doximity Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $0.57B $0.22B 38.88%
2024-12-31 $0.55B $0.20B 36.48%
2024-09-30 $0.52B $0.17B 33.66%
2024-06-30 $0.49B $0.16B 32.59%
2024-03-31 $0.48B $0.15B 31.16%
2023-12-31 $0.47B $0.14B 29.49%
2023-09-30 $0.45B $0.12B 27.46%
2023-06-30 $0.44B $0.12B 27.06%
2023-03-31 $0.42B $0.11B 26.73%
2022-12-31 $0.40B $0.11B 27.86%
2022-09-30 $0.39B $0.14B 35.06%
2022-06-30 $0.36B $0.15B 40.06%
2022-03-31 $0.34B $0.13B 38.95%
2021-12-31 $0.32B $0.12B 39.12%
2021-09-30 $0.28B $0.07B 26.26%
2021-06-30 $0.24B $0.04B 15.98%
2021-03-31 $0.21B $0.03B 13.53%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.613B $0.570B
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.259B 57.58
Hims & Hers Health (HIMS) United States $11.187B 92.56
Tempus AI (TEM) United States $10.529B 0.00
IRhythm Technologies (IRTC) United States $5.158B 0.00
Hinge Health (HNGE) United States $4.347B 0.00
Privia Health (PRVA) United States $2.493B 184.64
Inspire Medical Systems (INSP) United States $2.355B 34.62
Phreesia (PHR) United States $1.614B 0.00
Enovis (ENOV) United States $1.607B 8.49
10x Genomics (TXG) United States $1.516B 0.00
Omnicell (OMCL) United States $1.416B 27.28
Schrodinger (SDGR) United States $1.367B 0.00
Azenta (AZTA) United States $1.283B 55.96
Clover Health Investments (CLOV) United States $1.257B 0.00
Evolent Health (EVH) United States $1.082B 0.00
Claritev (CTEV) United States $1.013B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Standard BioTools (LAB) United States $0.486B 0.00
Zepp Health (ZEPP) Netherlands $0.461B 0.00
Talkspace (TALK) United States $0.412B 123.00
Carlsmed (CARL) $0.346B 0.00
Butterfly Network (BFLY) United States $0.342B 0.00
TruBridge (TBRG) United States $0.288B 50.50
Nyxoah SA (NYXH) Belgium $0.239B 0.00
Outset Medical (OM) United States $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
CapsoVision (CV) United States $0.190B 0.00
Health Catalyst (HCAT) United States $0.188B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.136B 0.00
American Well (AMWL) United States $0.112B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.075B 0.00
Pulmonx (LUNG) United States $0.063B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
HeartBeam (BEAT) United States $0.032B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00